Clarus Therapeutics (CRXT) null Earnings

30MarConfirmed
Jul 21
Nov 21
Q4 2021
Mar 22
-6.26
-4.24
-2.21
-0.19

Details

Expected EPS
-0.68
Actual EPS
-0.19
Surprise EPS
0.49
Surprise Percent
+72.06%

Description

Clarus Therapeutics (CRXT) has reported earnings of -0.19 per share for .

0 Comments

Share your thoughts